It is indicated to prevent invasive infections (sepsis, meningitis, and bacteremia) and respiratory tract infections such as otitis, sinusitis, and pneumonia caused by Streptococcus pneumoniae (also known as pneumococcus). The vaccine is inactivated and composed of molecules (polysaccharide) of the pneumococcal serotype capsule, conjugated to a protein. The administration is intramuscular. The National Immunization Program recommends two doses in the basic regimen, at 2 and 4 months, and a booster dose, at 12 months of age. There are two vaccines, the pneumococcal conjugate vaccine 10 valent (in SUS) and the pneumococcal conjugate vaccine 13 valent (in the private system).
The Vaccine Observatory studies routine vaccines indicated for children under two years of age (except flu and yellow fever), considering the recommendations of the National Immunization Schedule of the National Immunization Program of the Ministry of Health.